Literature DB >> 28462645

Spontaneous central venous thrombosis and shunt occlusion following peritoneovenous shunt placement for intractable ascites.

D Hariharan1, E A Wilkes1, G P Aithal1, S J Travis1, D N Lobo1.   

Abstract

A 43-year-old man had a peritoneovenous shunt inserted for the treatment of chylous ascites secondary to myelofibrosis. Despite being on anticoagulation for superior mesenteric vein thrombosis, he developed shunt dysfunction within two weeks of insertion. Superior venacavography showed multiple filling defects in the right axillary vein, no filling of the right brachiocephalic and right subclavian vein, and thrombotic occlusion of the internal jugular veins bilaterally. The shunt was removed 11 days after insertion, and there was extensive thrombosis of the venous end of the shunt and the compressible pump chamber. Shunt thrombosis is known to occur but remains a rare complication, with 87% of such obstructions being due to a thrombus at the tip of the venous end of the shunt. Extensive thrombosis of the shunt (as in the present case) is very rare.

Entities:  

Keywords:  Ascites; Chylous; Occlusion; Peritoneovenous shunt; Thrombosis

Mesh:

Year:  2017        PMID: 28462645      PMCID: PMC5449712          DOI: 10.1308/rcsann.2017.0058

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  12 in total

Review 1.  Denver peritoneovenous shunts for the management of malignant ascites: a review of the literature in the post LeVeen Era.

Authors:  Michael A White; Steven C Agle; Reema K Padia; Emmanuel E Zervos
Journal:  Am Surg       Date:  2011-08       Impact factor: 0.688

Review 2.  The peritoneovenous shunt: expectations and reality.

Authors:  M Moskovitz
Journal:  Am J Gastroenterol       Date:  1990-08       Impact factor: 10.864

3.  Prognosis assessment of patients with refractory ascites treated with a peritoneovenous shunt.

Authors:  Hidetoshi Nitta; Shigeki Okamura; Takao Mizumoto; Hiroo Matsushita; Takumasa Nishimura; Yasuhiro Shimokawa; Masami Kimura; Hideo Baba
Journal:  Hepatogastroenterology       Date:  2013-10

4.  Peritoneo-venous shunting for ascites.

Authors:  H H Leveen; G Christoudias; M Ip; R Luft; G Falk; S Grosberg
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

5.  Tissue factor antigen levels in various biological fluids.

Authors:  J Fareed; D D Callas; D Hoppensteadt; E W Bermes
Journal:  Blood Coagul Fibrinolysis       Date:  1995-06       Impact factor: 1.276

6.  Superior vena cava thrombosis treated by angioplasty and stenting in a cirrhotic patient with peritoneovenous shunt.

Authors:  Lorenzo Leggio; Ludovico Abenavoli; Luisa Vonghia; Luca Perrone; Giampaolo Niccoli; Beatrice Fusco; Daniele Gui; Lorenzo Bonomo; Andrea Donti; Roberto Di Bartolomeo; Giovanni Gasbarrini; Giovanni Addolorato
Journal:  Ann Thorac Cardiovasc Surg       Date:  2008-02       Impact factor: 1.520

7.  Recurrent ascites due to central venous thrombosis after peritoneojugular (LeVeen) shunt.

Authors:  C Smadja; D Tridard; D Franco
Journal:  Surgery       Date:  1986-09       Impact factor: 3.982

8.  LeVeen vs Denver peritoneovenous shunts for intractable ascites of cirrhosis. A randomized, prospective trial.

Authors:  J T Fulenwider; J D Galambos; R B Smith; J M Henderson; W D Warren
Journal:  Arch Surg       Date:  1986-03

9.  Disseminated intravascular coagulation with the peritoneovenous shunt.

Authors:  D C Harmon; Z Demirjian; L Ellman; J E Fischer
Journal:  Ann Intern Med       Date:  1979-05       Impact factor: 25.391

10.  Percutaneous placement and management of peritoneovenous shunts.

Authors:  Louis G Martin
Journal:  Semin Intervent Radiol       Date:  2012-06       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.